P. D. Delmas

Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment.

Patrick Garnero, W J Shih, Évelyne Gineyts et al. · The Journal of Clinical Endocrinology & Metabolism · 1994 · 682 citations · Full text

Bone Disease, Bone Health, Bone Markers +13

Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: A randomized, double-blind, placebo-controlled extension trial

Jonathan D. Adachi, Kenneth G. Saag, P. D. Delmas et al. · Arthritis & Rheumatism · 2001 · 547 citations

Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial

P. D. Delmas, Harry K. Genant, Gerald Crans et al. · Bone · 2003 · 539 citations

Skeletal Trauma, More Trial, Fracture Diagnostics +7

Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women.

Paweł Szulc, M C Chapuy, Pierre J. Meunier et al. · Journal of Clinical Investigation · 1993 · 483 citations · Full text

The Effect of Vitamin D Supplementation on Vitamin D Status and Parathyroid Function in Elderly Subjects*

Paul Lips, A Wiersinga, F C van Ginkel et al. · The Journal of Clinical Endocrinology & Metabolism · 1988 · 382 citations